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Abstract 
Aims: The aim of this study is to develop and validate a new method to diagnose apical 
hypertrophic cardiomyopathy (AHCM) by the integral quantitative analysis of myocardial perfusion 
and wall thickening from gated single-photon emission computed tomography (SPECT) 
myocardial perfusion imaging (MPI).  
Methods and results: Twenty-two consecutive patients, who showed T wave inversion≥3mm in 
precordial leads and sinus rhythm in electrocardiogram, were enrolled. All the patients underwent 
cardiac magnetic resonance (CMR), gated rest SPECT MPI and echocardiography. According to 
CMR diagnostic results, 13 patients were categorized as in the AHCM group and the remaining 9 
patients were categorized as in the non-AHCM group. Operators who were blinded to the CMR 
diagnosis independently performed the diagnosis by gated SPECT MPI. The regions of interest 
(ROIs) inside the apical hotspots on the perfusion polar map were drawn and the mean values of 
wall thickening in the drawn ROIs were calculated. Using MRI diagnosis as the gold standard, 
AHCM was diagnosed based on receiver operating characteristic (ROC) analysis of the mean 
wall thickening in the apical perfusion hotspot. The area under curve (AUC), sensitivity, specificity, 
and accuracy of our method were 0.97, 100%, 89%, and 95%, respectively.  
Conclusions: Our new method has high sensitivity, specificity, and accuracy against CMR 
diagnosis. It has great promise to become a clinical tool in the diagnosis of AHCM. 
 
 
 
 
Introduction 
Echocardiography is commonly used to screen apical hypertrophic cardiomyopathy (AHCM). A 
spade-like appearance of the left ventricular (LV) cavity and a wall thickness ≥15 mm of the LV 
apex are considered the diagnostic hallmark of AHCM [1, 2]. However, a transthoracic 
echocardiogram may be difficult to diagnose AHCM because of the suboptimal acoustic windows. 
The multiplane transesophageal echocardiogram allows high-resolution imaging of the LV apex 
[3], but it causes discomfort to patients. Cardiac magnetic resonance imaging (CMR) has recently 
become the gold standard to diagnose AHCM, because it can acquire high-quality and reliable 
3D images of the heart throughout the entire cardiac cycle [4-6]. However, the high medical cost, 
long scanning time and claustrophobia limit its wide clinical use. 
Due to low resolution and inaccuracy to measure the thickness of hypertrophic LV myocardium, 
the number of studies using myocardial perfusion imaging (MPI) to diagnose AHCM is very 
limited. Visual analysis based on increased apical tracer uptake and a characteristic solar map 
pattern on single photon emission computed tomography (SPECT) MPI has been used to 
diagnose AHCM [7, 8]. However, certain AHCM patients didn’t show this solar polar pattern [8]. 
Accordingly, these methods have limitations in the accuracy and reproducibility.  
It has been demonstrated that fractional wall thickening is inversely correlated with myocardial 
wall thickness [9]. Gated SPECT MPI can quantitatively assess LV functional parameters with 
high reproducibility and repeatability and thus has the promise to diagnose AHCM [10-12]. The 
aim of this study is to develop and validate a new method to diagnose AHCM by the integral 
quantitative analysis of myocardial perfusion and wall thickening from gated SPECT MPI.  
Methods 
Patient enrollment 
A total of twenty-two consecutive patients were enrolled in this study at Nanjing Medical University 
Hospital from September 2011 to October 2017. Inclusion criteria were: electrocardiogram (ECG) 
showed T wave inversion≥3mm in precordial leads and sinus rhythm. Exclusion criteria were: any 
of the coronary artery stenosis ≥ 50% by coronary angiography (CAG) or CT angiography (CTA), 
pericardial disease, congenital heart disease, hypertensive heart disease and congestive heart 
failure. All patients underwent CMR, gated rest SPECT MPI and echocardiography.  
The study was approved by Institutional Ethical Committee of the First Affiliated Hospital of 
Nanjing Medical University, and all patients gave written informed consent. 
CMR to diagnose AHCM 
CMR scans were performed using a 3.0T scanner (Magnetom Trio; Siemens, Erlangen, Germany) 
with surface coils and electrocardiographic gated triggering. The MR cines of two-chamber view, 
three-chamber view and four-chamber view were acquired using retrospective ECG gating 
steady-state free precession (SSFP) sequence. LV short-axis images were acquired from apex 
to base to cover the entire LV volume. Repeated breath-holds were required in order to create 
adequate images. The main sequence parameters of CMR cine included: TR, 61.5 ms; TE, 1.5 
ms; slice thickness, 8 mm; slice gap, 0; flip angle (FA), 50o; parallel acquisition technique factor, 
2 and bandwidth, 930 Hz/PX. The temporal resolution was 25 frames per RR interval.  
The diagnostic criteria in this study were the maximal wall thickness on the LV short-axis CMR 
image at the apex ≥12mm and the ratio of the maximal wall thickness on the LV short-axis CMR 
image at the apex to that of the base ≥1.3 [13]. 
SPECT MPI to diagnose AHCM 
The nuclear cardiology specialists who were blinded to MRI diagnosis processed the MPI images 
and performed independent diagnosis. The gated rest SPECT MPI was performed around 60 
minutes post injection of 20-30 mCi of Tc-99m sestamibi. SPECT planar images were acquired 
on a dual-headed camera (Philips Medical Systems, Milpitas, CA, USA) using a standard resting 
protocol. The imaging parameters were 20% energy window around 140KeV, 180o orbit, 32 steps 
with 25 seconds per step, 8-bin gating and 64 projections per gate. The total acquisition time was 
14 minutes for each patient. Image reconstruction and reorientation were completed with Emory 
Reconstruction Toolbox (ERToolbox; Atlanta, GA). SPECT images were reconstructed by ordered 
subset expectation maximization (OSEM) with 3 iterations and 10 subsets, and then filtered by a 
Butterworth low-pass filter with a cutoff frequency of 0.4 cycles/cm and an order of 10.  
The resulting short-axis images, as illustrated in Figure 1a, were input into Emory Cardiac Toolbox 
(ECToolbox; Atlanta, GA) to measure myocardial perfusion, mechanical dyssynchrony and wall 
thickening [8-10]. Both LV myocardial perfusion and wall thickening were reported as polar maps, 
as demonstrated in Figure 1b and 1c, respectively. A region of interest (ROI) drawing software 
tool was developed for the operators to manually specify the myocardial perfusion hotspot within 
the LV apical region on the perfusion polar map, as illustrated in Figure 1d. The ROI shape could 
be irregular. Multiple ROIs might be drawn for a single patient if multiple hotspots were present. 
Once drawn, the mean value of wall thickening in the ROI was calculated for the same region on 
the corresponding wall thickening polar map, as demonstrated in Figure 1e. When multiple ROIs 
were drawn, only the ROI with the smallest mean wall thickening was used for statistical analysis. 
Echocardiography to diagnose AHCM 
Echocardiography was performed in a semi-recumbent position and different degrees of left 
lateral decubitus for each patient using the Vivid E9 ultrasound system (GE Health Care, 
Wauwatosa, WI, USA). The interventricular septal and posterior wall thickness were measured 
from the parasternal long-axis view at end diastole. Maximal apical wall thickness was measured 
from the apical 4-chamber and apical 2-chamber and apical short-axis view at end diastole. The 
transducer was placed as low and as lateral as possible from the LV apical impulse in order to 
cover the maximal cavity section of the LV. Measurements were obtained from the apical 
endocardium to the visceral pericardium. The diagnostic criteria by echocardiography for AHCM 
was the same as the diagnostic criteria by CMR, i.e., the maximal wall thickness on the LV short-
axis at the apical level ≥12mm and ratio of the maximal wall thickness on the LV short-axis at the 
apical level to that at the basal level≥1.3. 
 
Statistical analysis 
All statistical analyses were performed with SPSS 19.0 (SPSS Inc., Chicago, IL, USA). Normal 
distributed continuous variables were expressed as mean ± SD. Using CMR as the gold standard, 
the receiver operating characteristic (ROC) analysis was applied into wall thickening 
measurements from gated SPECT MPI to diagnose AHCM. The Kappa value was calculated to 
observe the agreement. P<0.05 was considered to be statistically significant.  
Results   
Patient characteristics  
All the 22 patients were divided into AHCM and non-AHCM groups according to the CMR results. 
Table 1 shows the baseline characteristics of these two groups. The age was 58.50±12.21 years 
and body mass index (BMI) was 24.79±2.24. For the general clinical tests, 12 patients had 
hypertension, 1 had diabetes, 6 had typical angina, 7 had atypical angina, and 3 had palpitation. 
18 patients had T-waves inversion in lead V2-6, 9 had T-waves inversion in lead V3-4, 17 had ST 
segment depression, and 2 had ST segment elevation. For the LV mechanical dyssynchrony 
parameters by SPECT MPI, phase standard deviation (PSD) and phase bandwidth (PBW) were 
10.32±3.49o and 38.96±12.18o, respectively. All these general variables did not show a significant 
differences between the AHCM and non-AHCM groups (all P>0.05).  
Table 2 shows the LV myocardial viability, mechanical dyssynchrony, and wall thickening in ROIs 
between the AHCM and non-AHCM groups. There were no significant differences for myocardial 
perfusion, PSD, and PBW in ROIs between the two groups (all P>0.05). However, the wall 
thickening in the AHCM group was significantly smaller than that in the non-AHCM group (P<0.01). 
Diagnosis of apical hypertrophic cardiomyopathy 
Using MRI diagnosis as the gold standard, a ROC curve, shown in Figure 2, was generated for 
the mean values of the wall thickening in the perfusion hotspots. The cut-off value, AUC, sensitivity, 
specificity, and accuracy by SPECT MPI were 0.68, 0.97, 100%, 89%, and 95%, respectively. 
Only one patient who was in the non-AHCM group by CMR diagnosis was diagnosed by MPI to 
have ACHM, achieving a kappa value of 0.90 (95% confidence interval [CI]: 0.72 to 1.09). 
The consistency between echocardiography and MRI was moderate (Kappa value, 0.538; 95% 
CI, 0.184-0.892). The sensitivity, specificity, and accuracy by echocardiography were 77%, 78%, 
and 77%, respectively.  
Discussion 
To our knowledge, this is the first study to diagnose AHCM using the integral quantitative analysis 
of myocardial perfusion and wall thickening from gated SPECT MPI. The main finding is that our 
new method has excellent accuracy.  
Existing methods to diagnose AHCM by SPECT MPI  
A significant number of AHCM patients have inversion T wave in electrocardiogram and the 
symptoms of coronary artery disease (CAD), and thus are referred to SPECT MPI. Due to low 
resolution and inaccuracy to measure the thickness of hypertrophic LV myocardium, the number 
of studies using MPI to diagnose AHCM is very limited. Cianciulli et al revealed that an 
appearance of a significant increased apical tracer uptake, a spade-like LV deformity, and the 
solar polar map on SPECT MPI was considered AHCM [7]. Using echocardiography as the 
reference standard, they reported that the sensitivity and specificity of AHCM diagnosis by SPECT 
MPI were 75% and 100%. Ward et al [8] found that patients with AHCM had a characteristic solar 
polar map pattern caused by increased apical counts on rest MPI and a relative apical ischemia 
on the stress MPI. However, these two methods failed to explicitly explain why certain AHCM 
patients didn’t show the solar polar pattern [4]. As a result, the diagnosis methods based on visual 
analysis of SPECT MPI have limitations in the accuracy and reproducibility.  
Our new method to diagnose AHCM by gated SPECT MPI  
Dong et al [9] demonstrated that weak wall motion with decreased thickening capability indicated 
regional hypertrophic myocardium [14-17], so fractional wall thickening was inversely correlated 
with myocardial wall thickness. Mechanical interference between myocardial cells, increased 
connective tissue content, and decreased active force generation might be three reasons to 
explain the inverse correlation between fractional wall thickening and wall thickness [9]. Therefore, 
besides showing hotspots on perfusion polar map due to increased counts [7, 8], AHCM patients 
show decreased wall thickening inside the apical segment on the wall thickening polar map. 
Accordingly, the integral quantitative analysis on myocardial perfusion and wall thickening from 
widely practiced gated SPECT MPI has great promise to provide a clinical tool to improve the 
diagnosis of AHCM.  
Our new method has good accuracy. Using CMR as the gold standard, the sensitivity, specificity, 
and accuracy by our method were 100%, 89%, and 95%, respectively. Only one patient who was 
in the non-AHCM group by CMR was diagnosed to have AHCM by SPECT MPI. As shown in 
Figure 3, the decreased wall thickening is present in the perfusion hotspot ROI.  
In addition, several points may be noted: 1) Multiple perfusion hotspots may be present in the 
apical region of perfusion polar map for a single patient. Because regional wall thickening is 
inversely correlated with myocardial wall thickness and hypertrophic myocardial wall is located at 
the region with decreased wall thickening, only the ROI with the smallest mean wall thickening for 
each patient was input into the ROC analysis. 2) An interactive tool was provided to specify the 
ROIs of apical perfusion hotspot. Only ≥90% overall maximum perfusion level was considered the 
perfusion hotspot. It might be suggested that the ROIs be automatically extracted; however, in 
this pilot study, the interactive ROI specification provided significant flexibility. A new fully 
automatic tool may be developed in the following studies.  
We excluded the patients with any of the coronary artery stenosis≥50% by coronary angiography 
(CAG) or CT angiography (CTA), so stress perfusion studies were not needed to differentiate 
patients with AHCM showing ischemic changes in ECG from those with ischemic heart disease. 
Clinical implications 
A previous study [7] demonstrated that AHCM is easily diagnosed as CAD by mistake due to the 
similar symptoms such as marked ECG abnormalities and with or without chest pain, so the 
suspected AHCM patients are usually referred to radionuclide scans. Our method by widely 
practiced SPECT MPI may improve the cost-effectiveness. Most importantly, compared with 
existing methods, our method has good accuracy and reproducibility. 
Our method adds important new clinical values of cardiac functions to the diagnosis and prognosis 
of myocardial hypertrophy. While this study was targeted to apical hypertrophy, our method based 
on functional parameters from gated SPECT MPI may be generalized to detect myocardial 
hypertrophy at different locations and due to different reasons. LV hypertrophy may occur at only 
one to all LV segments [18] and myocardium may also thicken in normal individuals due to high 
blood pressure or prolonged athletic training. A recent study found that the apical morphological 
features of subjects with ECG abnormality were significantly different from normal subjects though 
the absolute thickness of apical wall was below the current diagnostic criteria of AHCM [17]. Since 
gated SPECT MPI is widely performed and can assess myocardial viability, mechanical 
dyssynchrony, and wall motion and thickening, in a single scan, our method may improve risk 
stratification for mild to severe myocardial hypertrophy as well. 
Study limitation 
The technical accuracy of the new method was tested in a relatively small sample size because 
AHCM is relatively rare, it has a relatively benign prognosis in terms of cardiovascular mortality 
and all the enrolled patients in this study required both CMR and gated rest SPECT MPI. A 
prospective study in a larger population is needed to validate clinical usefulness of this method. 
Conclusions 
A new method based on the integral quantitative analysis of myocardial perfusion and wall 
thickening from gated SPECT MPI has been developed and validated to diagnose AHCM. It has 
high diagnostic sensitivity (100%), specificity (89%), and accuracy (95%) against CMR. The 
method has great promise to become a clinical tool in the diagnosis of AHCM. 
 
Conflict of interest 
All the authors have no conflicts of interest to disclose. 
 
Funding  
This research was supported in part by an AHA grant (17AIREA33700016, PI: Weihua Zhou, PhD) 
and a New Faculty startup grant from the University of Southern Mississippi (DE01791, PI: 
Weihua Zhou, PhD). It was also supported by a grant from the Six Talents Peak Project of Jiangsu 
Province (2014-WSN-008, PI: Yanli Zhou).  
Reference 
1. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained cavity 
obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll 
Cardiol. 2003;42(2):288-95. 
2. Saccheri MC, Cianciulli TF, Morita LA, Méndez RJ, Beck MA, Guerra JE, et al. Speckle 
tracking echocardiography to assess regional ventricular function in patients with apical 
hypertrophic cardiomyopathy. World J Cardiol. 2017;9(4):363-370. 
3. Crowley JJ, Dardas PS, Shapiro LM: Assessment of apical hypertrophic cardiomyopathy 
using transesophageal echocardiography. Cardiology 1997.88:189,  
4. Parisi R, Mirabella F, Secco GG, Fattori R. Multimodality imaging in apical hypertrophic 
cardiomyopathy. World J Cardiol. 2014; 6(9): 916–923. 
5. Moon JC,  Fisher NG,  McKenna WJ,  Pennell DJ. Detection of apical hypertrophic 
cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic 
echocardiography. Heart, 2004; 90: 645-649. 
6. Kamal MU, Riaz IB, Janardhanan. Cardiovascular magnetic resonance imaging in 
hypertrophic cardiomyopathy: current state of the art. Cardiol J, 2016, 23:250–263. 
7. Cianciulli TF, Saccheri MC, Masoli OH, Redruello MF, Lax JA, Morita LA, et al. Myocardial 
perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J. Nucl. Cardiol. 
2009;16;391–395. 
8. Ward RP, Pokharna HK, Lang RM, Williams KA. Resting “solar polar” map pattern and 
reduced apical flow reserve: characteristics of apical hypertrophic on SPECT myocardial 
perfusion imaging. J Nucl Cardiology. 2003; 10(5): 506-512. 
9. Dong SJ, MacGregor JH, Crawley AP, McVeigh E, Belenkie I, Smith ER, et al. Left ventricular 
wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A 
three-dimensional tagged magnetic resonance imaging study. Circulation. 1994; 90(3): 1200–
1209. 
10. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular 
mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion 
SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical 
dyssynchrony. J Nucl Cardiol. 2005;12(6):687-95. 
11. Henneman MM, Chen J, Ypenburg C, Dibbets P, Bleeker GB, Boersma E, et al. Phase 
analysis of gated myocardial perfusion single-photon emission computed tomography 
compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J 
Am Coll Cardiol. 2007;49(16):1708-14. 
12. Zhou W, Garcia EV. Nuclear image-guided approaches for cardiac resynchronization therapy 
(CRT). Curr Cardiol Rep 2016;18(1):7.  
13. Suzuki J, Shimamoto R, Nishikawa J, Yamazaki T, Tsuji T, et al.Morphological onset and early 
diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic 
resonance imaging. J Am Coll Cardiol. 1999;33(1):146-51.  
14. Maier SE, Fischer SE, McKinnon GC, Hess OM, Krayenbuehl H-P, Boesiger P. Evaluation of 
left ventricular segment wall motion in hypertrophic cardiomyopathy with myocardial tagging. 
Circulation 1992;86:1919–1928.  
15. Kaul S, Tei C, Shah PM. Interventricular septal and free wall dynamics in hypertrophic 
cardiomyopathy. J Am Coll Cardiol 1983;4:1024–1030.  
16. Betocchi S, Hess OM, Losi MA, Nonogi H, Krayenbuehl HP. Regional left ventricular 
mechanics in hypertrophic cardiomyopathy. Circulation 1993;88(pt I):2206–2214.  
17. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, et al. Hypertrophic 
cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. 
J Am Coll Cardiol. 2009;54(3):220-8.  
18. Wu B, Lu M, Zhang Y, Song B, Ling J, et al. CMR assessment of the left ventricle apical 
morphology in subjects with unexplainable giant T-wave inversion and without apical wall 
thickness ≥15 mm. European Heart Journal – Cardiovascular Imaging. 2017; 18(2): 186-194.   
Table 1. Baseline characteristics of all the enrolled patients. 
 
Variables All(n=22) AHCM (n=13) Non-AHCM 
(n=9) 
P 
value 
Age(years) 58.50±12.21 60.31±12.85 55.89±11.45 0.418 
Male (n, %) 16 10 6 0.442 
BMI 24.79±2.24 24.35±2.37 25.44±1.97 0.270 
Hypertension  12 8 4 0.429 
Diabetes 1 1 0 0.219 
Typical angina 6 3 3 0.595 
Atypical angina 7 4 3 0.899 
Palpitation 3 1 2 0.329 
T wave inversion 6.05±2.38 6.46±2.37 5.44±2.40 0.336 
Inverted T wave in V2-
V6 
18 12 6 0.125 
Inverted T wave in V3-
V4 
9 5 4 0.779 
ST segment depression 17 10 7 0.784 
ST segment elevation 2 1 1 0.962 
PSD (degree)  10.32±3.49 10.77±2.44 9.66±4.72 0.474 
PBW(degree) 38.96±12.18 40.46±8.66 36.78±16.37 0.499 
 
Abbreviations: BMI, body mass index; PSD, phase standard deviation; PBW, phase bandwidth.  
 
  
  
 
 
Table 2. Myocardial viability, dyssynchrony, and wall thickening in ROIs 
 
Variables All(n=22) AHCM (n=13) Non-AHCM (n=9) P value 
Perfusion in ROI 0.9646±0.01 0.9648±0.01 0.9644±0.01 0.92 
PSD in ROI 4.18±3.60 4.74±3.53 3.38±3.76 0.40 
PBW in ROI 16.00±8.60 18.46±9.33 12.44±6.25 0.11 
Wall thickening in ROI 0.66±0.15 0.56±0.08 0.79±0.11 <0.01 
 
Abbreviations: ROI, region of interest; PSD, phase standard deviation; PBW, phase bandwidth. 
 
 Figure 1. Image processing of the perfusion and wall thickening polar maps generated from gated 
SPECT MPI. (a) Left-ventricular short-axis and long-axis images. (b) Perfusion polar map. (c) Wall 
thickening polar map. The color scale is shown between (b) and (c) to differentiate the 
quantification level. (d) Region of interest (ROI) in the hotspot drawn in the apical region on the 
perfusion polar map. (e) ROI on the corresponding wall thickening polar map. During the detection 
of apical hypertrophic myocardium, the operator manually drew the ROI in perfusion hotspot as 
illustrated in (d) and the mean value of wall thickening was automatically calculated in the entire 
ROI as illustrated in (e).  
 Figure 2. Receiver operating characteristic (ROC) analysis to diagnose apical hypertrophic 
cardiomyopathy by gated SPECT MPI. CMR was used as the gold standard. The area under 
curve (AUC), sensitivity, specificity, and accuracy of our method were 0.97, 100%, 89%, and 95%, 
respectively. ROC, receiver operating characteristic; SPECT, single-photon emission computed 
tomography; MPI, myocardial perfusion imaging; CMR, cardiac magnetic resonance imaging. 
  
 Figure 3. A patient who was in the non-AHCM group by CMR diagnosis was diagnosed to have 
AHCM by gated SPECT MPI. (a) Region of interest (ROI) in the hotspot drawn in the apical region 
on the SPECT perfusion polar map. (b) ROI on the corresponding wall thickening polar map. The 
deceased wall thickening can be observed in the ROI.  
 
We sincerely appreciate the comments from the reviewers and editor. Our 
point-by-point responses are as follows. 
 
Reviewer #1:  
1. Have not mentioned about stress studies at all in the revised 
manuscript though said it was done in response 
Re:  
1) Our method requires only rest gated SPECT MPI. It has high sensitivity (100%), 
specificity (89%), and accuracy (95%) against CMR diagnosis. Accordingly, stress 
imaging is unnecessary in our study. Nevertheless, our future study may test 
whether stress SPECT MPI can improve the accuracy. 
2) This is a retrospective study. All the enrolled patients received rest MPI but not all 
patients received both stress and rest MPI. In our last revision, we mentioned 
stress studies in our response to comments, but didn’t mention in our manuscript. 
More importantly, our method using rest-only MPI has high accuracy.  
3) Our current method using rest-only gated MPI may reduce the radiation dosage 
and increase the clinical applicability in the prospective study. It has great promise 
to become a clinical tool in the diagnosis of AHCM. 
 
2. Authors have mentioned that they did two days protocol with large 
dose in rest studies as patients were with large body habitus, though 
their patients' cohort was less than 25 (24.79) 
 
Re: A two-day imaging protocol is commonly performed in our center. Higher doses of 
the tracer are injected (20 to 30 mCi) both at rest and at peak stress in order to 
optimize myocardial count rate. Although Chinese patients do not have as large body 
habitus as western patients, Chinese doctors prefer 2-day protocol. 
 
 
3. They have not responded to query no.7 "Integral quantitative 
analysis has not been described in the manuscript" 
 
Re: We appreciate that the reviewer marked this point again. However,  
1) The Query 7 in the last revision: 7. What about SPECT MPI perfusion finding - any 
defect in apical area would result in decreased counts in that area (secondary to 
myocardial infarction or stress induced apical defects). It would defeat the purpose 
of study. 
Re: In our study, myocardial infarction was excluded by CAG or CTCA. Although 
many of these patients underwent both rest and stress MPI, we only used rest MPI 
images, so it will not defeat our purpose. 
2) Regarding the integral quantitative analysis, it is explained as follows in our 
method: A region of interest (ROI) drawing software tool was developed for the 
operators to manually specify the myocardial perfusion hotspot within the LV 
Response to Reviewers
apical region on the perfusion polar map, as illustrated in Figure 1d. The ROI 
shape could be irregular. Multiple ROIs might be drawn for a single patient if 
multiple hotspots were present. Once drawn, the mean value of wall thickening in 
the ROI was calculated for the same region on the corresponding wall thickening 
polar map, as demonstrated in Figure 1e. When multiple ROIs were drawn, only 
the ROI with the smallest mean wall thickening was used for statistical analysis 
 
 
4. Query 10 has not been addressed and rewritten as such without 
making sense. The statement is either from Dong et al (9) or from 
13-15). Need to correct. Similarly for query no. 11 
 
Re: There was no query 10 or 11. After double check, we guess that this 
reviewer refers to Query 8.  
The Query 8 in the last revision: 8. Reference no 13-15 have been quoted in the 
statement of Dong et al  (ref 9) without their relevance, need to re-write the sentence. 
Re: The sequence of reference has been corrected and the related modifications 
have been pasted below: 
Dong et al [9] demonstrated that weak wall motion with decreased thickening 
capability indicated regional hypertrophic myocardium [13-15], so fractional wall 
thickening was inversely correlated with myocardial wall thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following is the last revision:  
 
 
 
 
We sincerely appreciate the comments from the reviewers and editor. We have 
revised the manuscript accordingly. 
 
Reviewer Comments: 
 
Reviewer #1:  
1. Echocardiography is still the best modality to pick up AHCM and suboptimal 
acoustic window may be an issue in only few patients. The patients in this cohort must 
have undergone echocardiography (reference standard as mentioned in manuscript 
also), inclusion of findings of echo in the manuscript would make manuscript better. 
 
Re: All patients underwent echocardiography and we have added the method and the 
result of echocardiography in the manuscript (Page 5-7, the related modifications are 
pasted below). It is worth pointing out that the reproducibility of echocardiography is 
not very good. 
 
Echocardiography to diagnose AHCM 
Echocardiography was performed in a semi-recumbent position and different degrees 
of left lateral decubitus for each patient using the Vivid E9 ultrasound system (GE 
Health Care, Wauwatosa, WI, USA). The interventricular septal and posterior wall 
thickness were measured from the parasternal long-axis view at end diastole. 
Maximal apical wall thickness was measured from the apical 4-chamber and apical 
2-chamber and apical short-axis view at end diastole. The transducer was placed as 
low and as lateral as possible from the LV apical impulse in order to cover the 
maximal cavity section of the left ventricle. Measurements were obtained from the 
apical endocardium to the visceral pericardial. The diagnostic criteria by 
echocardiography for AHCM was the same as the diagnostic criteria by CMR, i.e., the 
maximal wall thickness on the LV short-axis at the apical level ≥12mm and ratio of the 
maximal wall thickness on the LV short-axis at the apical level to that at the basal 
level≥1.3. 
 
The consistency between echocardiography and MRI was moderate (Kappa value, 
0.538; 95% CI, 0.184-0.892). The sensitivity, specificity, and accuracy by 
echocardiography were 77%, 78%, and 77%, respectively.  
 
 
2. Patients in old age group might be having the coronary artery disease which may 
be discernible on stress MPI and that was not done here. That aspect needs 
explanation, as authors have mentioned that the patients with CAD were 
excluded  by angiography or CTCA. This itself exclude the need to do stress MPI. In 
these conditions: is there indication of doing MPI studies with radiation dose being 
delivered to patients and information is easily available with echo and CMR  
 
Re: In China, CAG or CTCA is more commonly used than MPI to diagnose CAD. So 
most of the patients with T wave inversion had undergone angiography and CTCA 
before MPI. A few of them were scheduled to do both rest and stress MPI. If the CAD 
was excluded, the patient would be scheduled to do echo or CMR. In order to fulfill our 
study, all the patients enrolled in our study underwent rest MPI, echocardiography and 
CMR, and all of them signed informed consent. 
 
 
 
3. Authors have mentioned about LV dyssynchrony showing global PSD and PBW 
values, however if feasible, it would have been better to have apical dyssynchrony 
values (regional) which might be different/higher in AHCM than non-AHCM due to 
hypertrophy rather than writing the global dyssynchrony values 
 
Re: We investigated the global dyssynchrony in both groups and expected to see if 
there was a statistically significant difference between AHCM and Non-AHCM patients, 
so reported the global PSD/PBW values. According to the reviewer’s suggestion, we 
have added Table 2 in the manuscript, including myocardial viability, dyssynchrony, 
and wall thickening parameters in the ROIs. There were no significant differences for 
myocardial perfusion, PSD, and PBW in ROIs between the two groups (all P>0.05). 
However, the wall thickening in the AHCM group was significantly smaller than that in 
the non-AHCM group (P<0.01).  
 
Table 2. Myocardial viability, dyssynchrony, and wall thickening in ROI 
Variables All(n=22) AHCM (n=13) Non-AHCM (n=9) P value 
Perfusion in ROI 0.9646±0.01 0.9648±0.01 0.9644±0.01 0.92 
PSD in ROI 4.18±3.60 4.74±3.53 3.38±3.76 0.40 
PBW in ROI 16.00±8.60 18.46±9.33 12.44±6.25 0.11 
Wall thickening in 
ROI 
0.66±0.15 0.56±0.08 0.79±0.11 <0.01 
Abbreviations: ROI, region of interest; PSD, phase standard deviation; PBW, phase 
bandwidth. 
 
 
4. Only rest gated MPI study was performed and dose of tracer seems to on higher 
side, needs explanation 
 Re: There are three basic protocols with Tc 99m-labeled tracers: (1) a single-day 
study, in which myocardial blood flow is interrogated at rest and at peak stress, or in 
the reverse order, as long as the first injected dose is low (8 to 10 mCi) and the 
second injected dose is high (22 to 30 mCi); (2) a 2-day study, (commonly performed 
in patients with large body habitus) in which higher doses of the tracer are injected (20 
to 30 mCi) both at rest and at peak stress in order to optimize myocardial count rate; 
and (3) a dual-isotope technique, which combines injection of thallium at rest followed 
by injection of a Tc 99m tracer at peak stress. In our hospital, we use a 2-day study, so 
the dose of tracer is higher than 1-day study. 
 
 
5. How the ROI drawing software tool has been developed and integral quantitative 
analysis (a table with quantitative values is desirable) has not been described in the 
manuscript so it can be better understood by readers also. 
 
Re: The software tool was developed by MATLAB and the related modification is 
pasted below. In addition, we added Table 2 in the manuscript which shows the 
quantitative analysis of myocardial perfusion, PSD, PBW, and wall thickening in ROIs. 
A region of interest (ROI) drawing software tool was developed for the operators to 
manually specify the myocardial perfusion hotspot within the LV apex region on the 
perfusion polar map, as illustrated in Figure 1d. The ROI shape could be irregular. 
Multiple ROIs might be drawn for a single patient if multiple hotspots were present. 
Once drawn, the mean value of wall thickening in the ROI was calculated for the same 
region on the corresponding wall thickening polar map, as demonstrated in Figure 1e. 
When multiple ROIs were drawn, only the ROI with the smallest mean wall thickening 
was used for statistical analysis. 
 
 
 
6. Age may be written with years in the manuscript. 
 
Re: Age has been written with years (page 6).  
 
 
 
7. What about SPECT MPI perfusion finding - any defect in apical area would result in 
decreased counts in that area (secondary to myocardial infarction or stress induced 
apical defects). It would defeat the purpose of study 
 
Re: In our study, myocardial infarction was excluded by CAG or CTCA. Although 
many of these patients underwent both rest and stress MPI, we only used rest MPI 
images, so it will not deteat our purpose. 
  
 
 
 
8. Reference no 13-15 have been quoted in the statement of Dong et al  (ref 9) 
without their relevance, need to re-write the sentence. 
 
Re: The sequence of reference has been corrected and the related modifications 
have been pasted below: 
Dong et al [9] demonstrated that weak wall motion with decreased thickening 
capability indicated regional hypertrophic myocardium [13-15], so fractional wall 
thickening was inversely correlated with myocardial wall thickness. 
 
 
 
 
9. Mean values for wall thickening in hot spot areas (in quantitative terms) have not 
been provided, which might have been better for understanding of readers.   
 
Re: We have added the Table 2 in the manuscript to show the mean values for wall 
thickening in hot spot areas. 
 
 
 
 
 
Reviewer #2: 
1. Is T-wave inversion > 3mm adequate? Usually ~1 cm inversion seen in apical 
hypertrophic cardiomyopathy needs explanation and referencing for use of these 
cutoffs. 
 
Re: The commonly used electrocardiogram finding in apical hypertrophic 
cardiomyopathy is giant negative T waves (GNT) (≥1 mV or 10 mm) in the left 
precordial leads. These GNT waves often change over time, or even disappear, as 
part of the natural history of AHCM. In our study, three patients had giant negative T 
waves (10 mm deep in leads V3-V6), whereas ten had lesser degrees of T-wave 
inversion (range, 3-9 mm). 
 
 
 
2. Earlier in the introduction, it is noted that 15 mm is the characteristic wall thickness 
noted in apical hypertrophic cardiomyopathy , but diagnostic criteria notes that any 
thickness > 12 mm is considered apical HCM. This needs explanation and backing up 
with references, else it seriously effects the validity of the work. 
 Re: A wall thickness of ≥15 mm is considered the diagnostic hallmark of AHCM by 
some researchers. However, because the apex is the thinnest part of the LV, many 
studies suggested that apical wall thickness ≥12 mm but less than 15 mm, or the ratio 
of apical maximal thickness to basal posterior wall ≥1.3, represents early stage of 
AHCM, we added a reference about the diagnostic criteria of AHCM (reference 13 in 
the manuscript). 
 
 
 
3.    In my opinion there should a bit more detail provided about how potential false 
positive causes of reduced myocardial wall thickening may effect results and how the 
study deals with them 
 
Re: Echocardiography and cardiac MRI pay more attention to the anatomical index, 
however, SPECT pays attention to the functional indicators. The reduced apical 
myocardial wall thickening may be an earlier signal for LV hypertrophy than the 
absolute wall thickness, especially for mild hypertrophy, which will remind the doctors 
to follow-up the patient with caution in order to diagnose AHCM as early as possible. 
 
 
 
Points 1 & 2 in my opinion can potentially question the works validity/potential clinical 
applicability & potential patient selection thus need to be beyond doubt 
Re: Please refer to our answers and the section clinical implication in our manuscript. 
 
 
 
 
 
 
 
